Cargando…

Irisin as a Novel Biomarker of Subclinical Atherosclerosis in Severe Obesity

Severe obesity (SO) can accelerate atherosclerosis and the onset of acute cardiovascular events. The diagnosis of atherosclerosis in the context of a high body mass index (BMI) can be challenging, making the identification of biomarkers clinically relevant. We aimed to assess the usefulness of irisi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carmona-Maurici, Júlia, Rosa, Araceli, Azcona-Granada, Natalia, Peña, Elionora, Ricart-Jané, David, Viñas, Anna, López-Tejero, Maria Dolores, Domingo, Joan Carles, Miñarro, Antonio, Baena-Fustegueras, Juan Antonio, Peinado-Onsurbe, Julia, Pardina, Eva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179106/ https://www.ncbi.nlm.nih.gov/pubmed/37175880 http://dx.doi.org/10.3390/ijms24098171

Ejemplares similares

Diet change affects intestinal microbiota restoration and improves vertical sleeve gastrectomy outcome in diet-induced obese rats
por: Rossell, Joana, et al.
Publicado: (2020)

Diabetic and dyslipidaemic morbidly obese exhibit more liver alterations compared with healthy morbidly obese
por: Pardina, Eva, et al.
Publicado: (2016)

Serum irisin and apelin levels and markers of atherosclerosis in patients with subclinical hypothyroidism
por: Yasar, Hamiyet Yilmaz, et al.
Publicado: (2019)

Novel myokine: irisin may be an independent predictor for subclinic atherosclerosis in Behçet's disease
por: Icli, Abdullah, et al.
Publicado: (2016)

Exists a role for serum irisin in Egyptian Behcet’s patients with subclinical atherosclerosis?
por: Ismail, Mohamed A., et al.
Publicado: (2022)

Irisin as a Novel Biomarker of Subclinical Atherosclerosis, Cardiovascular Risk and Severe Disease in Axial Spondyloarthritis
por: Remuzgo-Martínez, Sara, et al.
Publicado: (2022)

Association of serum irisin concentration with thyroid autoantibody positivity and subclinical hypothyroidism
por: Chen, Zhengyi, et al.
Publicado: (2021)

Diabetes Is the Main Factor Accounting for Hypomagnesemia in Obese Subjects
por: Lecube, Albert, et al.
Publicado: (2012)

Circulating Tryptase as a Marker for Subclinical Atherosclerosis in Obese Subjects
por: Moreno, María, et al.
Publicado: (2014)

Predictors of subclinical atherosclerosis in HIV
por: Fernández Soto, Julia, et al.
Publicado: (2023)

Relationship of YKL-40 and adiponectin and subclinical atherosclerosis in asymptomatic patients with type 1 diabetes mellitus from a European Mediterranean population
por: Aguilera, Eva, et al.
Publicado: (2015)

Circulating Irisin and Myostatin as Markers of Muscle Strength and Physical Condition in Elderly Subjects
por: Planella-Farrugia, Cristina, et al.
Publicado: (2019)

Circulating Irisin Levels Are Positively Associated with Metabolic Risk Factors in Sedentary Subjects
por: Moreno, María, et al.
Publicado: (2015)

Irisin ERKs the Fat
por: Wu, Jun, et al.
Publicado: (2014)

Irisin in Liver Cirrhosis
por: Kukla, Michał, et al.
Publicado: (2020)

The Potential Role of Irisin in Vascular Function and Atherosclerosis: A Review
por: Byun, Kyeongho, et al.
Publicado: (2020)

Irisin – a myth rather than an exercise-inducible myokine
por: Albrecht, Elke, et al.
Publicado: (2015)

Biomarkers of Subclinical Atherosclerosis in Patients with Autoimmune Disorders
por: Profumo, Elisabetta, et al.
Publicado: (2012)

Irisin and the therapeutic benefits of exercise
por: Spiegelman, Bruce M, et al.
Publicado: (2012)

Irisin, Two Years Later
por: Novelle, Marta G., et al.
Publicado: (2013)

The Role of Irisin in Alzheimer’s Disease
por: Kim, Oh Yoen, et al.
Publicado: (2018)

Irisin and Autophagy: First Update
por: Pesce, Mirko, et al.
Publicado: (2020)

Irisin: Still chasing shadows
por: Albrecht, Elke, et al.
Publicado: (2020)

Irisin and Secondary Osteoporosis in Humans
por: Zerlotin, Roberta, et al.
Publicado: (2022)

The Role of Irisin in Cancer Disease
por: Pinkowska, Agnieszka, et al.
Publicado: (2021)

Irisin, Exercise, and COVID-19
por: Alves, Hugo Rodrigues, et al.
Publicado: (2022)

Role of irisin in physiology and pathology
por: Liu, Shiqiang, et al.
Publicado: (2022)

Role of irisin in bone diseases
por: Zhao, Ruobing, et al.
Publicado: (2023)

Circulating Irisin Levels in Patients with Chronic Plaque Psoriasis
por: Ambrogio, Francesca, et al.
Publicado: (2022)

Subclinical hypothyroidism in childhood, treatment or only follow-up?
por: Murillo-Vallés, Marta, et al.
Publicado: (2020)

MON-533 Irisin in Post-Menopausal Women with Primary Hyperparathyroidism: An Interplay between Irisin and Pth
por: Palermo, Andrea, et al.
Publicado: (2019)

Renal failure suppresses muscle irisin expression, and irisin blunts cortical bone loss in mice
por: Kawao, Naoyuki, et al.
Publicado: (2022)

Circulating Irisin Levels as a Marker of Osteosarcopenic-Obesity in Cushing’s Disease
por: Guarnotta, Valentina, et al.
Publicado: (2020)

Irisin Is Elevated in Skeletal Muscle and Serum of Mice Immediately after Acute Exercise
por: Brenmoehl, Julia, et al.
Publicado: (2014)

Locus Characterization and Gene Expression of Bovine FNDC5: Is the Myokine Irisin Relevant in Cattle?
por: Komolka, Katrin, et al.
Publicado: (2014)

Exercise-induced irisin in bone and systemic irisin administration reveal new regulatory mechanisms of bone metabolism
por: Zhang, Jin, et al.
Publicado: (2017)

Serum irisin levels are decreased in patients with sepsis, and exogenous irisin suppresses ferroptosis in the liver of septic mice
por: Wei, Shasha, et al.
Publicado: (2020)

Irisin Enhances Osteoblast Differentiation In Vitro
por: Colaianni, Graziana, et al.
Publicado: (2014)

Adropin and Irisin in Patients with Cardiac Cachexia
por: Kalkan, Ali Kemal, et al.
Publicado: (2018)

Adropin and Irisin in Patients with Cardiac Cachexia
por: Mansur, Alfredo José
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cvmlqpoh4717d2r2ld2d8g8hmh